Clinical Trials Browser

INDUSTRY × melflufen × Plasma cell × Clear all

NCT03151811 2024-01-30

OCEAN

Phase 3 Terminated

495 enrolled 15 charts

Multiple Myeloma

NCT04649060 2023-06-08

LIGHTHOUSE

Phase 3 Terminated

54 enrolled 21 charts

Multiple Myeloma

NCT03639610 2023-03-10

BRIDGE

Phase 2 Terminated

35 enrolled 33 charts

Multiple Myeloma, Renal Insufficiency

NCT03481556 2022-12-19

ANCHOR

Phase 1/2 Terminated

56 enrolled 22 charts

Multiple Myeloma

NCT02963493 2022-11-22

HORIZON

Phase 2 Completed

157 enrolled 26 charts 1 FDA

Multiple Myeloma

NCT04115956 2022-03-28

A Clinical Study of Melphalan Flufenamide (Melflufen) and Dexamethasone for Patients With Immunoglobulin Light Chain (AL) Amyloidosis

Phase 1 Terminated

Immunoglobulin Light-chain Amyloidosis